Policy & Geopolitics
Axsome Surges 20% to All-Time High on FDA Priority Review for Alzheimer's Drug
Dec 31, 2025
You're signed outSign in or to get full access.
Leadership at Axsome Therapeutics
Browse executives, board members, and key leadership.
You're signed outSign in or to get full access.
Browse executives, board members, and key leadership.